Tamoxifen-resistant estrogen receptor (ER+) breast cancer has a strong positive relationship with increased MNK phosphorylation of eIF4E [22] and rapamycin-resistant KRASG12D colorectal cancer activated the MNK/eIF4E pathways with overexpression of c-MYC [23]. The gene discussed is EIF4E; the disease is breast cancer.